You are here:
Home
NICE Guidance
Conditions and diseases
Diabetes and other endocrinal, nutritional and metabolic conditions
Diabetes
Canagliflozin in combination therapy for treating type 2 diabetes
Technology appraisal guidance
Reference number:
TA315
Published:
25 June 2014
Guidance
Tools and resources
Information for the public
Evidence
History
Consultation
Add text here to discuss consultation
Back to top